Pharmafile Logo
Pharmafocus logo
Advanced Search
artificial_heart

CARMAT’s artificial heart commercially implanted successfully for third time

August 27, 2021
Medical Communications

CARMAT’s artificial heart, Aeson, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, has been …

News

New PPE mask range can begin to kill SARS-CoV-2 on contact

August 27, 2021
Medical Communications

A new PPE mask range has been launched that can begin to kill SARS-CoV-2 and other viruses and pathogens on …

News

Genetic cause of endometriosis identified alongside potential drug target

August 26, 2021

New research, published in Science Translational Medicine, has identified the genetic cause of endometriosis which in turn has identified a …

News

Malaria sickness could be cut by 70%, study finds

August 26, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have found a new approach to protecting young African …

News
astrazeneca_plaque_web_3

Positive Phase III trial results for AstraZeneca in flushing copper from tissues

August 26, 2021

AstraZeneca’s ALXN1840 demonstrated approximately three times greater copper mobilisation from tissues than standard-of-care treatments.Results from the FoCus Phase III trial …

News

NHS blood tests halted due to vial shortages

August 26, 2021

The NHS has suspended some blood testing due to a shortage in collection tube supplies following warnings from Becton Dickinson …

News

NHS England planning for possible jab roll out to 12-15 year-olds

August 26, 2021

NHS England is preparing for a possible extension of the COVID vaccination programme to all 12 to 15-year-olds.This will be …

News

Trial planned to investigate ketamine in treatment-resistant depression

August 25, 2021
Research and Development

HMNC Brain Health and Develco Pharma have partnered to develop an investigational oral prolonged-release formulation of ketamine, targeting treatment-resistant depression …

News
mark

Stelis Biopharma appoints Mark Womack as new CEO

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.Womack is also the …

Appointment

PureTech appoints Julie Krop as Chief Medical Officer

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.Krop will oversee all clinical development, Regulatory, CMC, and …

Appointment

Tracey Lodie appointed Chief Scientific Officer of Quell Therapeutics

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Quell Therapeutics has announced the appointment of Tracey Lodie as Chief Scientific Officer.Dr Lodie brings to Quell more than 20 …

Appointment
anita_cooper_002

RareCan appoints Dr Anita Cooper as Non-Executive Director

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.Cooper has over 30 years’ experience in global business …

Appointment

Laura Steele appointed President and General Manager for Lilly UK

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Eli Lilly and Company have announced that Laura Steele has been appointed President and General Manager (GM) for UK, Ireland …

Appointment

Medical cannabis: The next innovation in oncology?

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp …

Feature
drugcosts-edt-jumbo

Pharma disputes, fines, and the work of the CMA

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS …

Feature

One-time gene therapy sees promising results in children with AADC deficiency

August 25, 2021
Research and Development

A pioneering approach to gene therapy delivery has been published in the European Molecular Biology Organization Journal on Wednesday, wherein …

News

Generic asthma inhaler to offer NHS significant savings

August 25, 2021
Research and Development

Luforbec 100/6 pMDI, the first branded generic alternative to Fostair 100/6 pMDI, to treat adult asthma and severe chronic obstructive …

News

Protection from COVID-19 vaccines starts to wane within six months

August 25, 2021
Research and Development

Researchers are starting to see that protection from the COVID-19 vaccines begins to wane within sixe months of receiving a …

News

Pfizer to buy Trillium for $2.26 billion

August 25, 2021
Research and Development

Pfizer will buy Trillium, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, for $2.26 billion.Trillium’s …

News

Sackler family face “substantial risk” of liability over opioid crisis

August 24, 2021
Manufacturing and Production

The judge overseeing Purdue Pharma’s bankruptcy said that some members of the Sackler family, owners of OxyContin, face a “substantial …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025